Literature DB >> 12383210

Subclassification of renal cell neoplasms: an update for the practising pathologist.

A A Renshaw1.   

Abstract

The classification of renal cell neoplasms has been extensively studied in the last decade, and a standardized nomenclature adopted. Although this system is based on a combination of genetic, histological and immunohistological features, in most cases accurate classification can be based on histological features alone. This review summarizes the key features of the tumours included in this system, and then focuses on diagnostic difficulties that can arise when using this system, as well as reviewing several recently characterized tumours that are not yet included.

Entities:  

Mesh:

Year:  2002        PMID: 12383210     DOI: 10.1046/j.1365-2559.2002.01420.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  15 in total

Review 1.  Epigenetic regulation in RCC: opportunities for therapeutic intervention?

Authors:  James Larkin; Xin Yi Goh; Marcus Vetter; Lisa Pickering; Charles Swanton
Journal:  Nat Rev Urol       Date:  2012-01-17       Impact factor: 14.432

2.  Typing of renal tumors by morphological and immunocytochemical evaluation of fine needle aspirates.

Authors:  Margareta Strojan Fležar; Helena Gutnik; Jera Jeruc; Irena Srebotnik Kirbiš
Journal:  Virchows Arch       Date:  2011-11-04       Impact factor: 4.064

3.  Renal cell carcinoma in a pediatric patient with an inherited mitochondrial mutation.

Authors:  Surasak Sangkhathat; Takeshi Kusafuka; Akihiro Yoneda; Seika Kuroda; Yukichi Tanaka; Mio Tanaka; Norio Sakai; Masahiro Fukuzawa
Journal:  Pediatr Surg Int       Date:  2005-10-20       Impact factor: 1.827

4.  Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis.

Authors:  Ozgur Mete; Isin Kilicaslan; Mine G Gulluoglu; Veli Uysal
Journal:  Virchows Arch       Date:  2005-08-17       Impact factor: 4.064

5.  A renal cell carcinoma with components of both chromophobe and papillary carcinoma.

Authors:  Michael H A Roehrl; Martin K Selig; G Petur Nielsen; Paola Dal Cin; Esther Oliva
Journal:  Virchows Arch       Date:  2006-11-24       Impact factor: 4.064

6.  Highly expressed lncRNA CRNDE promotes cell proliferation through Wnt/β-catenin signaling in renal cell carcinoma.

Authors:  Kun Shao; Tianming Shi; Yang Yang; Xianghui Wang; Da Xu; Peijun Zhou
Journal:  Tumour Biol       Date:  2016-10-06

7.  Keratin immunohistochemistry in renal cell carcinoma subtypes and renal oncocytomas: a systematic analysis of 233 tumors.

Authors:  Cord Langner; Beate J Wegscheider; Manfred Ratschek; Luigi Schips; Richard Zigeuner
Journal:  Virchows Arch       Date:  2004-01-16       Impact factor: 4.064

8.  Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression.

Authors:  Gan Yu; Weimin Yao; Kiranmai Gumireddy; Anping Li; Ji Wang; Wei Xiao; Ke Chen; Haibing Xiao; Heng Li; Kun Tang; Zhangqun Ye; Qihong Huang; Hua Xu
Journal:  Mol Cancer Ther       Date:  2014-09-23       Impact factor: 6.261

9.  Multimodal imaging and detection strategy with 124 I-labeled chimeric monoclonal antibody cG250 for accurate localization and confirmation of extent of disease during laparoscopic and open surgical resection of clear cell renal cell carcinoma.

Authors:  Stephen P Povoski; Nathan C Hall; Douglas A Murrey; David S Sharp; Charles L Hitchcock; Cathy M Mojzisik; Eamonn E Bahnson; Michael V Knopp; Edward W Martin; Robert R Bahnson
Journal:  Surg Innov       Date:  2012-03-27       Impact factor: 2.058

10.  Fabrication of mAb G250-SPIO molecular magnetic resonance imaging nanoprobe for the specific detection of renal cell carcinoma in vitro.

Authors:  Cailuan Lu; Jingjing Li; Kai Xu; Chun Yang; Jiali Wang; Cuiping Han; Xiaohua Liu
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.